Loading...
You are here:  Home  >  Health  >  Current News

Pfizer immuno-oncology drug wins U.S. approval for bladder cancer



(Reuters) - U.S. health regulators on Tuesday granted accelerated approval for Pfizer Inc's immuno-oncology drug Bavencio to treat advanced bladder cancer, marking the second approval in less than two months for the treatment developed along with Germany's Merck KGaA.


Other News

Athletics: Hotel says it’s not to blame for athletes’ stomach bug LONDON (Reuters) - The London hotel at the center of an outbreak of sickness that has struck down scores of competitors at the World Athletics Champ...
Pennsylvania poised to legalize medical marijuana use HARRISBURG, Pa. (Reuters) - Pennsylvania was poised to become the 24th U.S. state to legalize marijuana use for medical purposes after state legisla...
Lack of exercise costs world $67.5 billion and 5 million lives a year LONDON (Reuters) - A study of one million people has found that physical inactivity costs the global economy $67.5 billion a year in healthcare and ...

Found news:

Loading...

You might also like...

GlaxoSmithKline adult shingles vaccine wins U.S. approval

Read More →